传染科指南

订阅

MedSci主页 / 所有栏目 / 传染科指南

2022 IATDMCT立场声明：万古霉素治疗药物监测的最佳实践

2022-01-10 国际治疗药物监测和临床毒性协会 Ther Drug Monit

万古霉素细菌组治疗药物监测

2022年，国际治疗药物监测和临床毒性协会(IATDMCT)发布了万古霉素治疗药物监测的最佳实践声明。与固定或经验给药策略相比，基于治疗药物监测（TDM）数据的万古霉素个体化给药可以改善患者预后。

中文标题：

2022 IATDMCT立场声明：万古霉素治疗药物监测的最佳实践

英文标题：

Optimal Practice for Vancomycin Therapeutic Drug Monitoring: Position Statement From the Anti-infectives Committee of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology

发布机构：

国际治疗药物监测和临床毒性协会

发布日期：

2022-01-10

简要介绍：

2022年，国际治疗药物监测和临床毒性协会(IATDMCT)发布了万古霉素治疗药物监测的最佳实践声明。与固定或经验给药策略相比，基于治疗药物监测（TDM）数据的万古霉素个体化给药可以改善患者预后。本文主要针对万古霉素治疗药物监测的最佳临床时间提供指导建议。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2022 IATDMCT立场声明：万古霉素治疗药物监测的最佳实践.pdf)] GetToolGuiderByIdResponse(projectId=1, id=c258f1c002320ebc, title=2022 IATDMCT立场声明：万古霉素治疗药物监测的最佳实践, enTitle=Optimal Practice for Vancomycin Therapeutic Drug Monitoring: Position Statement From the Anti-infectives Committee of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology, guiderFrom=Ther Drug Monit, authorId=0, author=, summary=2022年，国际治疗药物监测和临床毒性协会(IATDMCT)发布了万古霉素治疗药物监测的最佳实践声明。与固定或经验给药策略相比，基于治疗药物监测（TDM）数据的万古霉素个体化给药可以改善患者预后。, cover=https://img.medsci.cn/2022114/1642139806793_1608702.png, journalId=0, articlesId=null, associationId=1995, associationName=国际治疗药物监测和临床毒性协会, associationIntro=国际治疗药物监测和临床毒性协会(IATDMCT,International Association of Therapeutic Drug Monitoring and Clinical Toxicity), copyright=0, guiderPublishedTime=Mon Jan 10 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">2022年，国际治疗药物监测和临床毒性协会(IATDMCT)发布了万古霉素治疗药物监测的最佳实践声明。与固定或经验给药策略相比，基于治疗药物监测（TDM）数据的万古霉素个体化给药可以改善患者预后。本文主要针对万古霉素治疗药物监测的最佳临床时间提供指导建议。</span></p>, tagList=[TagDto(tagId=1840, tagName=万古霉素), TagDto(tagId=26540, tagName=细菌组), TagDto(tagId=58401, tagName=治疗药物监测)], categoryList=[CategoryDto(categoryId=9, categoryName=传染科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=10, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4682, appHits=40, showAppHits=0, pcHits=407, showPcHits=4642, likes=0, shares=6, comments=2, approvalStatus=1, publishedTime=Fri Jan 14 13:55:44 CST 2022, publishedTimeString=2022-01-10, pcVisible=1, appVisible=1, editorId=0, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=dajiong, createdTime=Fri Jan 14 13:58:53 CST 2022, updatedBy=1608702, updatedName=dajiong, updatedTime=Sat Jan 06 20:29:36 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2022 IATDMCT立场声明：万古霉素治疗药物监测的最佳实践.pdf)])
2022 IATDMCT立场声明：万古霉素治疗药物监测的最佳实践.pdf
下载请点击：
评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1186741, encodeId=dec51186e41d8, content=学习了 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3818101931, createdName=wjl066452, createdTime=Fri Jan 21 10:41:26 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184458, encodeId=b75a118445877, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Sat Jan 15 07:22:08 CST 2022, time=2022-01-15, status=1, ipAttribution=)]
    2022-01-21 wjl066452

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1186741, encodeId=dec51186e41d8, content=学习了 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3818101931, createdName=wjl066452, createdTime=Fri Jan 21 10:41:26 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184458, encodeId=b75a118445877, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Sat Jan 15 07:22:08 CST 2022, time=2022-01-15, status=1, ipAttribution=)]
    2022-01-15 微探

    学习学习

    0

相关指南

2020 ASHP/IDSA/PIDS/SIDP共识指南：万古霉素治疗严重MRSA感染的治疗药物监测

美国卫生系统药师协会(ASHP,American Society of Health-System Pharmacists) · 2020-03-19

万古霉素个体化给药临床药师指引

中国药师专家小组（统称） · 2015-02-11

2012年万古霉素临床应用剂量中国专家共识

中国呼吸科专家组（统称） · 2012-09-12

万古霉素临床应用中国专家共识(2011版)

中国新药与临床杂志 · 2011-09-08